McKinley Carter Wealth Services Inc. Grows Stock Holdings in Metlife Inc (NYSE:MET)

McKinley Carter Wealth Services Inc. boosted its holdings in Metlife Inc (NYSE:MET) by 16.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,968 shares of the financial services provider’s stock after buying an additional 1,810 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in Metlife were worth $644,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in MET. North Point Portfolio Managers Corp OH purchased a new position in shares of Metlife during the 2nd quarter valued at $224,000. Clarius Group LLC grew its position in shares of Metlife by 9.2% during the 2nd quarter. Clarius Group LLC now owns 6,486 shares of the financial services provider’s stock valued at $322,000 after purchasing an additional 544 shares in the last quarter. Employers Holdings Inc. purchased a new position in shares of Metlife during the 2nd quarter valued at $387,000. Capital Wealth Planning LLC purchased a new position in shares of Metlife during the 2nd quarter valued at $315,000. Finally, Comerica Bank grew its position in shares of Metlife by 0.3% during the 2nd quarter. Comerica Bank now owns 252,273 shares of the financial services provider’s stock valued at $12,604,000 after purchasing an additional 711 shares in the last quarter. Institutional investors and hedge funds own 75.13% of the company’s stock.

Shares of NYSE MET traded up $0.62 during mid-day trading on Friday, reaching $45.35. 7,142,900 shares of the company were exchanged, compared to its average volume of 6,161,309. Metlife Inc has a 52 week low of $37.76 and a 52 week high of $51.16. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $41.89 billion, a PE ratio of 8.41, a PEG ratio of 0.94 and a beta of 1.09. The company’s 50 day moving average price is $49.07 and its 200 day moving average price is $46.70.

Metlife (NYSE:MET) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.07. Metlife had a net margin of 9.28% and a return on equity of 9.75%. The company had revenue of $16.45 billion during the quarter, compared to the consensus estimate of $16.43 billion. During the same period in the previous year, the firm posted $1.30 EPS. The firm’s revenue was down 22.4% compared to the same quarter last year. On average, sell-side analysts predict that Metlife Inc will post 5.65 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Tuesday, August 6th will be issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.88%. The ex-dividend date is Monday, August 5th. Metlife’s dividend payout ratio is currently 32.65%.

A number of research firms have recently commented on MET. Morgan Stanley boosted their price target on shares of Metlife from $52.00 to $53.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 10th. Wells Fargo & Co boosted their price target on shares of Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, July 11th. Citigroup set a $42.00 price target on shares of Metlife and gave the company a “sell” rating in a research report on Thursday, May 23rd. ValuEngine lowered shares of Metlife from a “hold” rating to a “sell” rating in a research report on Thursday, August 1st. Finally, Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price target for the company in a research report on Friday, August 2nd. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $49.71.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: What is an investor looking for in an SEC filing?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.